Matinas BioPharma to Webcast Conference Call Discussing Third Quarter 2020 Financial and Operational Results on November 6, 2020
ET to discuss operational and financial results for the third quarter ended September 30, 2020.
- ET to discuss operational and financial results for the third quarter ended September 30, 2020.
- The live webcast will be accessible on the Investors section of Matinas website, www.matinasbiopharma.com , and will be archived for 90 days.
- Matinas BioPharma is a clinical-stage biopharmaceutical company focused on developing next generation therapeutics to advance standards of care for patients in areas of significant unmet medical need.
- Matinas BioPharmas product candidates are all in a development stage and are not available for sale or use.